## Promoters

| Name | Element Type | Cell type |
| ----------- | ----------- | ----------- |
| F9 | Hemophilia B | HepG2 |
| FOXE1 | Thyroid cancer | HeLa |
| GP1BB | Bernard-Soulier Syndrome |  HEL 92.1.7 |
| HBB | Thalassemia | HEL 92.1.7 |
| HBG1 | Hereditary persistence of fetal hemoglobin | HEL 92.1.7 |
| HNF4A (P2) | Maturity-onset diabetes of the young (MODY) | HEK293T |
| LDLR | Familial hypercholesterolemia | HepG2 |
| MSMB | Prostate cancer | HEK293T |
| PKLR | Pyruvate kinase deficiency | K562 |
| TERT | Various types of cancer | HEK293T, SF7996 |

## Enhancers 

| Name | Element Type | Cell type |
| ----------- | ----------- | ----------- |
| BCL11A+58 | Sickle cell disease | HEL 92.1.7 |
| IRF4 | Human pigmentation | SK-MEL-28 |
| IRF6 | Cleft lip | HaCaT |
| MYC (rs6983267) | Various types of cancer | HEK293T | 
| MYC (rs11986220) | Various types of cancer | LNCaP + 100nM DHT |
| RET | Hirschsprung | Neuro-2a |
| SORT1 | Plasma low-density lipoprotein cholesterol & myocardial infarction | HepG2 |
| TCF7L2 | Type 2 diabetes | MIN6 |
| UC88 | - | Neuro-2a |
| ZFAND3 | Type 2 diabetes | MIN6 | 
| ZRS | Limb malformations | NIH/3T3 (with HOXD13/ HOXD13+HAND2) |

